Application of an ATP-Bioluminescence Assay in Ovarian Cancer Chemosensitivity Testing in Vitro

Jiangyan Lou,Zhilan Peng,Shanling Liu,He Wang

DOI: https://doi.org/10.3969/j.issn.1672-173X.2000.04.038

2000-01-01

Abstract:This study was aimed to make an evaluation of ATP-bioluminescence assay (ATP-CVA) in ovarian cancer chemosensitivity testing in vitro and to analyze the correlation between in vitro results and in vivo response. ATP-CVA was used to determine the drug sensitivity of 25 specimens of fresh ovarian cancer cells. The ATP levels of drug-exposed tumor cell cultures were compared with those of control cultures, and based on the percentage decrease in ATP levels, drug sensitivity was evaluated. A decrease of >70% was defined as strong sensitivity (SS), 50%-70% as partially sensitivity (PS), <50% as resistance (RR). Patients' responses were obtained by accepted clinical assessment methods after six treatment courses. The results showed that in a range of 10-9-10-5mol/ml, there was a linear relationship between the log ATP and the log luminescence, Y = 1.48X + 15.03, correlation coefficient r = 0.9963. In this study 25 fresh specimens of ovarian cancer were subjected to ATP chemosensitivity assays. 22 Assays were completed successfully, yielding an evaluability rate of 88% (22/25). The correlation between clinical responses and in vitro data on chemosensitivity was evaluated retrospectively. The sensitivity was 85.7%, specificity 83.3%, positive predictive value 92.3%, negative predictive value 71.4%, and the total predictive accuracy 85%. This study demonstrated a good correlation between in vitro results and in vivo response. It is worth further clinical investigation.